Name: Xilio Therapeutics, Inc. (XLO) Balance Sheet
Creator: FinSpry

Xilio Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Xilio Therapeutics, Inc. (XLO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	55.29	44.70	120.39	198.05	19.24
Cash & Short-Term Investments	55.29	44.70	120.39	198.05	19.24
Accounts Receivable	2.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.94	3.42	4.11	4.46	1.35
Total Current Assets	60.23	48.13	124.50	202.52	20.59
Non-Current Assets
Property, Plant & Equipment (Net)	9.06	11.07	13.06	13.90	14.06
Long-Term Investments	1.78	0.00	0.00	0.00	0.00
Other Non-Current Assets	1.78	1.73	1.61	1.64	1.66
Total Non-Current Assets	10.84	12.80	14.67	15.54	0.00
Total Assets	71.08	60.93	139.17	218.06	36.32
Current Liabilities
Accounts Payable	2.57	11.55	3.13	3.14	5.44
Short-Term Debt	1.19	3.32	6.67	0.00	2.33
Current Portion of Long-Term Debt	0.00	3.32	6.67	0.00	2.33
Accrued Liabilities	9.98	5.81	10.33	8.75	13.73
Deferred Revenue	13.52	0.00	0.00	0.00	0.00
Other Current Liabilities	9.98	0.05	0.08	0.08	0.00
Total Current Liabilities	27.26	15.96	21.12	12.78	22.16
Non-Current Liabilities
Long-Term Debt	6.95	8.14	3.17	9.63	7.81
Other Non-Current Liabilities	0.00	0.00	0.05	0.12	0.54
Total Non-Current Liabilities	26.22	8.14	12.40	19.85	0.00
Total Liabilities	53.48	24.10	33.52	32.63	41.60
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00
Retained Earnings	-383.75	-325.51	-249.11	-160.89	-85.09
Additional Paid-in Capital	401.35	362.34	354.75	346.31	0.00
Shares Outstanding	45.76	27.61	27.43	27.36	0.00
Total Stockholders' Equity	17.60	36.83	105.65	185.43	-5.29
Total Liabilities & Equity	71.08	60.93	139.17	218.06	0.00